Rotation widens
The post-election bid finally leaked out of mega-cap defensives and into plain-vanilla cyclicals. Chemicals and ag inputs took the baton, and Mosaic (MOS) finished as the top performer in the S&P 500. This wasn’t a fertilizer-price moonshot. It was a reward for guardrails.
MOS laid down a tighter operating frame: 2027 SG&A below $500M and CapEx below $1B, with phosphate curtailments continuing. That mix matters because it changes the cycle math. If supply stays tighter than the Street assumed and management is willing to run leaner—lower overhead, lower capital intensity—you get a cleaner free-cash-flow profile without needing perfect commodity tape. Investors could underwrite that, so they paid for it.
One day doesn’t fix the fertilizer cycle. But it does show what gets funded right now: fewer “trust us” stories, more line items you can model.
Earnings, quality first
The cleanest single-name reaction was AppLovin (APP): beat, stock up. The pitch is simple—visible monetization, operating leverage, and a model that doesn’t require heroic assumptions. The market will still pay for that when the print matches the narrative.
Across the rest of the tape, the grading rubric stayed consistent: EPS beats driven by cost control don’t carry much weight if revenue looks messy. Investors want to know whether demand is real before they celebrate efficiency.
- Tenaya Therapeutics: Q3 GAAP EPS -$0.08 (beat $0.02); revenue $1.7M (beat $0.9M). “Less bad” helps the runway story, but it’s still early.
- ATN International: Q3 GAAP EPS $1.09 (beat $0.90); revenue $183.2M (miss $1.7M). EPS upside, slight revenue miss—durability becomes the debate.
- Barrett Business: Q3 Non-GAAP EPS $0.69 (in line); revenue $334.1M (beat $1.9M). Solid, uneventful.
- Purple Innovation: Q3 GAAP EPS -$0.33 (beat $0.92); revenue $96.51M (miss $9.21M). Costs improved faster than demand—good control, weak growth signal.
- Excelerate Energy: Q3 Non-GAAP EPS $0.44 (beat $0.01); revenue $297.2M (miss $48.04M). That revenue gap stands out when investors are already skeptical of timing noise in energy-linked names.
- Liberty Latin America: reported Q3 (no figures provided).
AI: platforms lead, chips wobble
AI capex is still the macro inside the market, but leadership stayed narrow. Platforms with perceived pricing power and capacity constraints caught bids; parts of semis looked like the easiest place to trim risk without touching the index.
Microsoft (MSFT) rose on the cloud supply/demand framing—tight capacity is being treated as supportive for backlog and pricing. Amazon (AMZN) also pushed higher, with commentary pointing to a $424B market-cap move tied to cloud dynamics. When the market swings that much weight around, it’s telling you who’s steering the tape.
On the other side of the trade:
- Qualcomm (QCOM) fell on Apple exposure concerns plus memory-cost pressure. Customer concentration plus rising inputs isn’t a combo investors want.
- Micron (MU) slid as traders revisited AI/data center cycle timing—digestion, inventory, and the path to the next leg.
- Sony (SONY) was flat; the market treated it as a visibility issue, not a catalyst.
Software had its own version of the same tension: AI growth versus AI cost. Figma was mixed after Q3 revenue $391M (beat guidance by $16M), with attention shifting to heavier AI investment pushing costs up. Growth gets funded; margin pushouts don’t get a free pass.
The day’s message was straightforward: the market will pay for discipline and throughput, but it won’t subsidize sloppy revenue or open-ended AI spend.